SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2016 |
|---|---|
| Enthalten in: |
Nature medicine - (2016) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schneider, Constanze [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1038/nm.4255 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1989580289 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1989580289 | ||
| 003 | DE-627 | ||
| 005 | 20230715025808.0 | ||
| 007 | tu | ||
| 008 | 170207s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1038/nm.4255 |2 doi | |
| 028 | 5 | 2 | |a PQ20170206 |
| 035 | |a (DE-627)OLC1989580289 | ||
| 035 | |a (DE-599)GBVOLC1989580289 | ||
| 035 | |a (PRQ)crossref_primary_10_1038_nm_42550 | ||
| 035 | |a (KEY)0272729320160000000000000000samhd1isabiomarkerforcytarabineresponseandatherape | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Schneider, Constanze |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Oellerich, Thomas |4 oth | |
| 700 | 1 | |a Baldauf, Hanna-Mari |4 oth | |
| 700 | 1 | |a Schwarz, Sarah-Marie |4 oth | |
| 700 | 1 | |a Thomas, Dominique |4 oth | |
| 700 | 1 | |a Flick, Robert |4 oth | |
| 700 | 1 | |a Bohnenberger, Hanibal |4 oth | |
| 700 | 1 | |a Kaderali, Lars |4 oth | |
| 700 | 1 | |a Stegmann, Lena |4 oth | |
| 700 | 1 | |a Cremer, Anjali |4 oth | |
| 700 | 1 | |a Martin, Margarethe |4 oth | |
| 700 | 1 | |a Lohmeyer, Julian |4 oth | |
| 700 | 1 | |a Michaelis, Martin |4 oth | |
| 700 | 1 | |a Hornung, Veit |4 oth | |
| 700 | 1 | |a Schliemann, Christoph |4 oth | |
| 700 | 1 | |a Berdel, Wolfgang E |4 oth | |
| 700 | 1 | |a Hartmann, Wolfgang |4 oth | |
| 700 | 1 | |a Wardelmann, Eva |4 oth | |
| 700 | 1 | |a Comoglio, Federico |4 oth | |
| 700 | 1 | |a Hansmann, Martin-Leo |4 oth | |
| 700 | 1 | |a Yakunin, Alexander F |4 oth | |
| 700 | 1 | |a Geisslinger, Gerd |4 oth | |
| 700 | 1 | |a Ströbel, Philipp |4 oth | |
| 700 | 1 | |a Ferreirós, Nerea |4 oth | |
| 700 | 1 | |a Serve, Hubert |4 oth | |
| 700 | 1 | |a Keppler, Oliver T |4 oth | |
| 700 | 1 | |a Cinatl, Jindrich |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Nature medicine |d New York, NY : Nature Publ. Co., 1995 |g (2016) |w (DE-627)182598845 |w (DE-600)1220066-9 |w (DE-576)044282524 |x 1078-8956 |7 nnns |
| 773 | 1 | 8 | |g year:2016 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1038/nm.4255 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_168 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2120 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |j 2016 | ||